[1] |
Stephan C, Vincendeau S, Houlgatte A , et al. Multicenter evaluation of [-2]proprostate-specific antigen and the prostate health index for detecting prostate cancer[J]. Clin Chem, 2013,59(1):306-314.
|
[2] |
黄宜, 王文涓, 许静 , 等. p2PSA及其相关指标 PHI 在前列腺癌诊断中的应用价值[J]. 检验医学, 2019,34(7):600-604.
|
[3] |
Quinn D, Gross M . Show us a sign: the search for "game changing" prostate cancer biomarkers[J]. Lancet Oncol, 2011,12(3):204-206.
|
[4] |
Vukovic I, Djordjevic D, Bojanic N , et al. Predictive value of [-2]propsa(p2psa) and its derivatives for the prostate cancer detection in the 2.0 to 10.0 ng/mL PSA range[J]. Int Braz J Urol, 2017,43(1):48-56.
|
[5] |
朱耀, 唐钵, 戴波 , 等. 前列腺健康指数在中国男性前列腺癌诊断中的应用研究[J]. 中华外科杂志, 2017,55(10):734-737.
|
[6] |
闫存玲, 李志艳, 何群 , 等. 血清前列腺特异性抗原同源异构体-2在前列腺癌中的应用价值[J]. 中华检验医学杂志, 2015,38(12):813-817.
|
[7] |
Catalona WJ, Partin AW, Sanda MG , et al. A multicenter study of [-2]pro-prostate specific antigen combined with prostate speci-fic antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range[J]. J Urol, 2011,185(5):1650-1655.
|
[8] |
Jansen FH, van Schaik RHN, Kurstjens J , et al. Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection[J]. Eur Urol, 2010,57(6):921-927
|
[9] |
Fossati N, Buffi NM, Haese A , et al. Preoperative prostate speci-fic antigen isoform p2PSA and its derivatives, %p2PSA and prostate health index, predict pathologic outcomes in patients undergoing radical prostatectomy for prostate cancer: results from a multicentric European prospective study[J]. Eur Urol, 2015,68(1):132-138
|
[10] |
Eminaga O, Bögemann M, Breil B , et al. Preoperative prostate-specific antigen isoform p2PSA ≤ 22.5 pg/ml predicts advanced prostate cancer in patients undergoing radical prostatectomy[J]. Urol Oncol, 2014,32(8):1117-1126.
|
[11] |
Guazzoni G, Lazzeri M, Nava L , et al. Preoperative prostate-specific antigen isoform p2PSA and its derivatives, %p2PSA and prostate health index, predict pathologic outcomes in patients undergoing radicalprostatectomy for prostate cancer[J]. Eur Urol, 2012,61(3):455-466.
|
[12] |
Schwen ZR, Tosoian JJ, Sokoll LJ , et al. Prostate Health Index (PHI) Predicts High-stage Pathology in African American Men[J]. Urology, 2016,90:136-140.
|
[13] |
Dolejsova O, Kucera R, Fuchsova R , et al. The ability of Prostate Health Index (PHI) to predict gleason score in patients with prostate cancer and discriminate patients between gleason score 6 and gleason score higher than 6: a study on 320 patients after radical prostatectomy[J]. Technol Cancer Res Treat, 2018,17:1-6.
|
[14] |
Chiu PK, Lai FM, Teoh JY , et al. Prostate health index and %p2PSA predict aggressive prostate cancer pathology in Chinese[J]. Ann Surg Onclo, 2016,23(8):2707-2714.
|
[15] |
王友林, 朱磊一, 姜波 , 等. 超声引导下经直肠前列腺穿刺与前列腺癌根治术后病理组织Gleason评分差异性的研究[J]. 临床泌尿外科杂志, 2015,30(7):628-630.
|